These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 71663)

  • 1. Hyperacute autoimmune encephalomyelitis induced by a synthetic autoantigen.
    Westall FC; Thompson M; Lennon VA
    Nature; 1977 Sep; 269(5627):425-7. PubMed ID: 71663
    [No Abstract]   [Full Text] [Related]  

  • 2. Response of rat encephalitogenic T cells to synthetic peptides of guinea pig myelin basic protein.
    Vandenbark AA; Hashim G; Offner H
    Ann N Y Acad Sci; 1988; 540():337-9. PubMed ID: 2462807
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-encephalitogenic antigen-induced suppression and reversal of allergic encephalomyelitis.
    Hashim GA
    Nature; 1975 Aug; 256(5518):953-5. PubMed ID: 52118
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-encephalitogenic synthetic analogues of the determinant for allergic encephalomyelitis in guinea pigs.
    Hashim GA; Sharpe RD
    Nature; 1975 Jun; 255(5508):484-5. PubMed ID: 49022
    [No Abstract]   [Full Text] [Related]  

  • 5. Minimum structural requirements for encephalitogen and for adjuvant in the induction of experimental allergic encephalomyelitis.
    Nagai Y; Akiyama K; Suzuki K; Kotani S; Watanabe Y; Shimono T; Shiba T; Kusumoto S; Ikuta F; Takeda S
    Cell Immunol; 1978 Jan; 35(1):158-67. PubMed ID: 74289
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of the encephalitogenic activities of human myelin basic protein and the synthetic peptide determinant comprising residues 114-122.
    McDermott JR; Caspary EA
    J Neurochem; 1975 Nov; 25(5):711-3. PubMed ID: 53275
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental allergic encephalomyelitis: activation of myelin basic protein-sensitized spleen cells by specific antigen in culture.
    Richert JR; Driscoll BF; Kies MW; Alvord EC
    Cell Immunol; 1981 Mar; 59(1):42-53. PubMed ID: 6163562
    [No Abstract]   [Full Text] [Related]  

  • 8. Modulation of the immunologic response of myelin basic protein by extrinsic and intrinsic factors.
    Nagai Y
    Neurology; 1976 Jun; 26(6 PT 2):45-6. PubMed ID: 58395
    [No Abstract]   [Full Text] [Related]  

  • 9. T cell recognition in experimental autoimmune encephalomyelitis: prospects for immune intervention with synthetic peptides.
    Wraith DC; Smilek DE; Mitchell DJ; Steinman L; McDevitt HO
    Int Rev Immunol; 1990; 6(1):37-47. PubMed ID: 1715375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergic encephalomyelitis induced in guinea pigs by a peptide from the NH2-terminus of bovine P2 protein.
    Brostoff SW; Powers JM; Weise MJ
    Nature; 1980 May; 285(5760):103-4. PubMed ID: 6154892
    [No Abstract]   [Full Text] [Related]  

  • 11. Strain differences in susceptibility to experimental allergic encephalomyelitis and the immune response to the encephalitogenic determinant in inbred guinea pigs.
    Teitelbaum D; Webb C; Arnon R; Sela M
    Cell Immunol; 1977 Mar; 29(2):265-71. PubMed ID: 67899
    [No Abstract]   [Full Text] [Related]  

  • 12. Allergic encephalomyelitis: modification of the response by synthetic membrane structures containing bovine myelin basic protein and cerebroside.
    Brostoff SW; Powers JM
    Brain Res; 1975 Jul; 93(1):175-81. PubMed ID: 49214
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppression of autoimmunity via microbial mimics of altered peptide ligands.
    Steinman L; Utz PJ; Robinson WH
    Curr Top Microbiol Immunol; 2005; 296():55-63. PubMed ID: 16323420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of high-dose antigen therapy in experimental autoimmune encephalomyelitis: rapid induction of Th1-type cytokines and inducible nitric oxide synthase.
    Weishaupt A; Jander S; Brück W; Kuhlmann T; Stienekemeier M; Hartung T; Toyka KV; Stoll G; Gold R
    J Immunol; 2000 Dec; 165(12):7157-63. PubMed ID: 11120847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definition and synthesis of the essential amino acid sequence for experimental allergic encephalomyelitis in Lewis rats.
    Hashim GA; Carvalho EF; Sharpe RD
    J Immunol; 1978 Aug; 121(2):665-70. PubMed ID: 79612
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral tolerance in experimental autoimmune encephalomyelitis: specificity of peptide-induced oral tolerance.
    Javed NH; Gienapp I; Cox K; Whitacre CC
    Ann N Y Acad Sci; 1996 Feb; 778():393-4. PubMed ID: 8611001
    [No Abstract]   [Full Text] [Related]  

  • 17. Live imaging of effector cell trafficking and autoantigen recognition within the unfolding autoimmune encephalomyelitis lesion.
    Kawakami N; Nägerl UV; Odoardi F; Bonhoeffer T; Wekerle H; Flügel A
    J Exp Med; 2005 Jun; 201(11):1805-14. PubMed ID: 15939794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demyelinating disease: an immunological model for studies of neural antigens.
    Hashim GA
    Gerontology; 1987; 33(3-4):181-6. PubMed ID: 2443426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmunity to myelin basic protein.
    Swanborg RH; Holda JH; Killen JA
    Adv Exp Med Biol; 1982; 150():3-22. PubMed ID: 6183945
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiple discrete encephalitogenic epitopes of the autoantigen myelin basic protein include a determinant for I-E class II-restricted T cells.
    Zamvil SS; Mitchell DJ; Powell MB; Sakai K; Rothbard JB; Steinman L
    J Exp Med; 1988 Sep; 168(3):1181-6. PubMed ID: 2459291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.